Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-18 6:39 pm Purchase | 2025-06-20 | 13D | NUCANA PLC SPONSORED ADR 2 NCNA | Hugh S. Griffith | 2,829,961,890 12.000% | 2,829,960,730 (+243962131.90%) | Filing History |
| 2025-04-18 6:04 pm Purchase | 2025-04-18 | 13D | NUCANA PLC SPONSORED ADR NCNA | Carlyle Group Inc. CG | 17,150 2.400% | 16,479 (+2455.89%) | Filing History |
| 2025-02-25 5:03 pm Sale | 2024-06-28 | 13D | NUCANA PLC SPONSORED ADR NCNA | Sofinnova Venture Partners VIII, L.P. | 255 0.100% | -1,002 (-79.71%) | Filing History |
| 2025-02-14 4:32 pm Purchase | 2025-02-14 | 13D | NUCANA PLC SPONSORED ADR NCNA | Sofinnova Capital VI FCPR | 24,940 5.100% | 45 (+0.18%) | Filing History |
| 2024-10-04 10:14 am Purchase | 2024-09-30 | 13G | NUCANA PLC SPONSORED ADR NCNA | BAILLIE GIFFORD & CO | 4,588 1.620% | 3,856 (+526.78%) | Filing History |
| 2024-02-27 4:29 pm Sale | 2023-12-27 | 13D | NUCANA PLC SPONSORED ADR RPST NCNA | Sofinnova Venture Partners VIII, L.P. | 1,257 11.900% | -359 (-22.22%) | Filing History |
| 2024-02-14 4:26 pm Purchase | 2023-12-31 | 13G | NUCANA PLC SPONSORED ADR RPST NCNA | Hugh S. Griffith | 1,160 11.000% | 201 (+20.96%) | Filing History |
| 2024-01-26 06:31 am Unchanged | 2023-12-29 | 13G | NUCANA PLC SPONSORED ADR RPST NCNA | BAILLIE GIFFORD & CO | 732 6.980% | 0 (Unchanged) | Filing History |
| 2023-02-13 4:16 pm Purchase | 2022-12-31 | 13G | NUCANA PLC SPONSORED ADR RPST NCNA | Hugh S. Griffith | 959 9.200% | 179 (+22.95%) | Filing History |
| 2023-02-13 3:54 pm Sale | 2023-02-14 | 13G | NUCANA PLC SPONSORED ADR RPST NCNA | Capital International Investors | 0 0.000% | -595 (Position Closed) | Filing History |
| 2023-01-23 10:37 am Unchanged | 2022-12-30 | 13G | NUCANA PLC SPONSORED ADR RPST NCNA | BAILLIE GIFFORD & CO | 732 7.010% | 0 (Unchanged) | Filing History |
| 2022-08-11 4:58 pm Purchase | 2022-08-01 | 13D | NUCANA PLC SPONSORED ADR RPST NCNA | Carlyle Group Inc. CG | 671 6.400% | 671 (New Position) | Filing History |
| 2022-02-25 7:34 pm Purchase | 2021-11-18 | 13D | NUCANA PLC SPONSORED ADR RPST NCNA | Sofinnova Venture Partners VIII, L.P. | 1,616 15.500% | 7 (+0.44%) | Filing History |
| 2022-02-11 4:13 pm Purchase | 2021-12-31 | 13G | NUCANA PLC SPONSORED ADR RPST NCNA | Hugh S. Griffith | 780 7.100% | 117 (+17.65%) | Filing History |
| 2022-02-11 12:22 pm Sale | 2022-02-14 | 13G | NUCANA PLC SPONSORED ADR RPST NCNA | Capital Research Global Investors | 0 0.000% | -916 (Position Closed) | Filing History |
| 2022-02-11 11:19 am Sale | 2022-02-14 | 13G | NUCANA PLC SPONSORED ADR RPST NCNA | Capital International Investors | 595 5.700% | -288 (-32.62%) | Filing History |
| 2022-01-27 09:41 am Purchase | 2021-12-31 | 13G | NUCANA PLC SPONSORED ADR RPST NCNA | BAILLIE GIFFORD & CO | 732 7.010% | 68 (+10.24%) | Filing History |
| 2021-06-15 4:46 pm Sale | 2021-05-20 | 13D | ASCENDIS PHARMA A/S SPONSORED ASND | Sofinnova Capital VI FCPR | 4,978,993 9.700% | -819,849 (-14.14%) | Filing History |